2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3312
  



  

  
Submitter : 
  

  
Mrs. Brenda O'Reilly
  

  
Date & Time: 
  

  
12/15/2006 08:12:56
  



  

  
Organization : 
  

  
Mrs. Brenda O'Reilly
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 please do not engage in the horrendous use of fetal body parts for vaccines or any other pharmaceutical.

Our technology and scienentific expertise is such that we do not need to stoop to these levels of desecrating human remains.